Director, Global Commercial Development - Immunology & Inflammation

ROLE SUMMARY:

The I&I Global Commercial Development (CD) Team is working to strengthen our portfolio by advancing assets and partnering with the Research Units and Business Development (BD) on new opportunities.

The colleague in this role will be the global commercial lead for the I&I Gastroenterology pipeline. They will lead commercial development activities through decision points, development of strategies for the GI therapeutic area and for pre-proof-of-concept (POC) programs, development of Product Concepts and investment priorities, and commercial assessments.

In partnership with cross functional colleagues, this individual will interface with and provide strategic guidance to the Research Units involved in I&I drug discovery. The role is global in scope and has responsibility to incorporate cross region needs into strategic and development plans. The position of Director, Commercial Development for I&I will report into the I&I Commercial DevelopmentTeam Leader.

ROLE RESPONSIBILITIES:
  • Global Commercial Lead for Gastrointestinal development programs; lead teams through governance steps to endorse next stages of development (FIH, POC Study start and Ph3 Start decisions)
  • Lead robust strategic and commercial evaluations to support Ph3-start governance decisions for phase 2 GI assets (Ritlecitinib CD, TL1A UC), including:

    o Lead a cross-functional commercial sub-team to align around key insights and inputs to inform commercial assessment and recommendations

    o Build and maintain a global revenue forecast model

    o Partner to lead primary and secondary research to support analyses

    o Liaise with regional and local colleagues as needed to inform global forecast, including representatives from EU, EM, Japan and China

    o Establish appropriate scenarios and evaluate potential risks and sensitivities

    o Collaborate with PHI/H&V colleagues on pricing analyses and strategy (including country-level), and evidence data needs to meet HTA markets; make recommendations on tradeoffs for global pipeline programs.
  • Lead and ensure appropriately robust, consistent and thorough commercial assessments are undertaken for early stage assets
  • Provide commercial and strategic guidance to early asset medicine teams, informing development strategies, portfolio prioritization, clinical study designs and geographic footprints; ensure that assets are developed into commercially viable, differentiated products
  • Work to develop and refine disease area strategies, aligning with WRD and GPD Lead
  • Partner with CI team to maintain an up-to-date view of the competitive landscape and potential threats across key rheumatology indications
  • Be a key contributor to the GI Disease Area Working Group (DAWG), e.g.:

    o Lead development and refinement of I&I Product Concepts

    o Identify new opportunities in GI, including lifecycle indications for existing assets, BD opportunities, and new "breakthrough" indication opportunities

    o Review and evaluate implications of new competitor data
  • Support other I&I strategic initiatives as needed
  • Develop and manage budgets diligently


The ideal candidate will have:
  • Strong strategic thinking and leadership skills
  • Ability to generate deep, targeted customer insights and integrate into business decisions
  • Excellence in analytical and forecasting capabilities, including a high proficiency with excel, scenario development incorporating trade-off implications in decision analysis
  • Ability to bring patient needs, and marketing lens to clinical development design and evidence priorities
  • Ability to lead cross functional teams, and partner with medical and WRD scientific colleagues
  • Agility to balance short- and long-term priorities and multiple projects
  • Ability to navigate unconscious bias, creative an objective decision case, drive options analyses
  • Ability to synthesize complex information and distill critical customer driven insights
  • Demonstrated problem-solving, decision-making capabilities
  • Strong project and process management skills
  • Excellent verbal and written communication skills
  • Enthusiasm, confidence and organizational skills to independently work on multiple initiatives, and effectively prioritize to meet personal and team goals


QUALIFICATIONS:

Minimum Qualifications:
  • Bachelor's degree with a minimum 7 years pharmaceutical industry experience in one or more of the following disciplines: marketing, strategy, new product launch, business development or analytics
  • Commercial experience with clinical development and global regulatory process, experience partnering with R&D colleagues in facilitating technical strategy and clinical development decisions
  • Strong skills in market research methodologies, and working with commercial partner Lines (Market Analytics, Market Access, etc.) to ensure delivery of efficient/insightful external guidance
  • Global and or US experience


Preferred experience:
  • Experience in Inflammation (Dermatology, Gastroenterology, Rheumatology etc.) strongly preferred
  • MBA and/or advanced science degree not required but preferred
  • Global Marketing and/or global commercial development experience


NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS 3
  • Occasional Business Travel between NYC, Collegeville and Cambridge (once COVID travel restrictions lifted)
  • Occasional international travel when needed (e.g. 1-2 times per year)


Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Other Job Details:
  • Last Date to Apply for Job: September 22, 2021
  • Eligible for Employee Referral Bonus


#LI-PFE

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Marketing and Market Research

#LI-PFE